Introduction to Special Issue: Targeted Toxins for Glioma Therapy Raj K. Puri Editorial Introduction Pages: 1 - 2
Transferrin Receptor Ligand-Targeted Toxin Conjugate (Tf-CRM107) for Therapy of Malignant Gliomas Michael WeaverDouglas W. Laske OriginalPaper Pages: 3 - 14
Interleukin-4-Pseudomonas Exotoxin Chimeric Fusion Protein for Malignant Glioma Therapy Mariko KawakamiKoji KawakamiRaj K. Puri OriginalPaper Pages: 15 - 25
Progress Report of a Phase I Study of the Intracerebral Microinfusion of a Recombinant Chimeric Protein Composed of Transforming Growth Factor (TGF)-α and a Mutated form of the Pseudomonas Exotoxin Termed PE-38 (TP-38) for the Treatment of Malignant Brain Tumors John H. SampsonGamal AkabaniIra Pastan OriginalPaper Pages: 27 - 35
Interleukin-13 Receptor-Directed Cytotoxin for Malignant Glioma Therapy: From Bench to Bedside Syed R. HusainRaj K. Puri OriginalPaper Pages: 37 - 48
BR96–DOX Immunoconjugate Targeting of Chemotherapy in Brain Tumor Models Leslie L. MuldoonEdward A. Neuwelt OriginalPaper Pages: 49 - 62
Targeting the Over-Expressed Urokinase-Type Plasminogen Activator Receptor on Glioblastoma Multiforme Edward RustamzadehChunbin LiDaniel A. Vallera OriginalPaper Pages: 63 - 75
Combination Fusion Protein Therapy of Refractory Brain Tumors: Demonstration of Efficacy in Cell Culture Tie Fu LiuKimberly A. CohenArthur E. Frankel OriginalPaper Pages: 77 - 85
